StreetInsider.com News Articles

Nova Mentis Assigns Intellectual Property

Tue, 27 Aug 2024 09:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - August 27, 2024) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company") is pleased to announce it has entered into an intellectual property conveyance agreement (the "Agreement") with Ludwig Enterprises Inc. ("LUDG") and Dr. Marvin S. Hausman ("Hausman"), CEO of Ludwig, pursuant to which the Company shall assign to Ludwig all of its intellectual property and patent of the mRNA Neuro Panel and Serotonin Assay, along with any and all data accumulated testing these assays (the "Property").

Under the terms of the Agreement, in consideration of the assignment of

Nova Mentis Assigns Intellectual Property

Tue, 27 Aug 2024 09:00:00 -0400

Under the terms of the Agreement, in consideration of the assignment of